Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.17 USD
Change Today +0.0651 / 5.92%
Volume 310.7K
BIOD On Other Exchanges
Symbol
Exchange
BIOD is not on other exchanges.
As of 12:37 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gerard J. Michel MS, MBA

Former Chief Financial Officer, Chief Accounting Officer, Vice President of Corporate Development and Treasurer, Biodel Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

51$452,271
As of Fiscal Year 2013

Background*

Mr. Gerard J. Michel, MS, MBA has been Chief Financial Officer and Vice President of Corporate Development at Aastrom Biosciences, Inc. since June 2014 and also serves as its Corporate Secretary. Mr. Michel served as the Chief Financial Officer, Vice President of Corporate Development and Treasurer of Biodel Inc. from November 20, 2007 to May 30, 2014 and also served as its Chief Accounting Officer. He oversaw strategic development, fundraising and capital structure ...

Read Full Background

Corporate Headquarters*

100 Saw Mill Road
Danbury, Connecticut 06810

United States

Phone: 203-796-5000
Fax: 203-796-5001

Board Members Memberships*

2007-N/A
Former Director, Member of Compensation Committee, Member of Nominating Committee and Member of Audit Committee

Education*

MS
University of Rochester
BS
University of Rochester
MBA
University of Rochester

Other Affiliations*

Annual Compensation*

Salary$204,167
Total Annual Compensation$204,167

Stock Options*

All Other Compensation$19,021
Exercisable Options6,187
Unexercisable Options71,813
Total Number of Options78,000

Total Compensation*

Total Annual Cash Compensation$306,021
Total Short Term Compensation$204,167
Other Long Term Compensation$19,021
Total Calculated Compensation$452,271
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIOD:US $1.17 USD +0.0651

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robin C. Stracey Interim Chief Executive Officer and Director
Cesca Therapeutics Inc.
--
Marc H. Hedrick M.D.Chief Executive Officer, President, Director and Member of Executive Committee
Cytori Therapeutics, Inc.
$437.4K
Martin M. McGlynn Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc
StemCells Inc.
$789.5K
David J. Mazzo B.A (Hons), B.Sc. (Hons.), M.Sc., Ph.D.Chief Executive Officer and Director
Neostem, Inc.
--
Martin P. Rosendale Chief Executive Officer and Director
Nuo Therapeutics, Inc.
$385.0K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIODEL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.